Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C

doi:10.3748/wjg.v16.i14.1747

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3474)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

311

HTML

2769

Figures (1-2)

203

Tables (1-4)

191

Sum=3474

Apr 14, 2010 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 14, 2010; 16(14): 1747-1752
Published online Apr 14, 2010. doi: 10.3748/wjg.v16.i14.1747

Full Size Figure Download Figure

Figure 2 Serum prohepcidin concentrations in chronic hepatitis C during antiviral therapy with respect to the treatment response. R: Responders [HCV-RNA undetectable 6 mo after the end of pegylated interferon (PEG-IFN) + ribavirin (RBV) therapy]; NR: Non-responders (HCV-RNA positive 6 mo after the end of PEG-IFN + RBV therapy).

Citation: Jaroszewicz J, Rogalska M, Flisiak I, Flisiak R. Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C. World J Gastroenterol 2010; 16(14): 1747-1752
URL: https://www.wjgnet.com/1007-9327/full/v16/i14/1747.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i14.1747